143 related articles for article (PubMed ID: 29882232)
21. Hyperacute graft-versus-host disease: histological assessment of skin biopsy specimens from 19 cases.
Shiohara J; Takata M; Shiohara M; Ito T; Ishida F
Clin Exp Dermatol; 2012 Jun; 37(4):335-40. PubMed ID: 22276575
[TBL] [Abstract][Full Text] [Related]
22. Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
Akpek G; Joseph R; Günay C; Kessler II; Shvartsbeyn M; Bhatnagar B; Aurelian L
Biol Blood Marrow Transplant; 2013 Apr; 19(4):529-37. PubMed ID: 23313704
[TBL] [Abstract][Full Text] [Related]
23. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
24. Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features.
Lehman JS; Gibson LE; el-Azhary RA; Chavan RN; Hashmi SK; Lohse CM; Flotte TJ
J Cutan Pathol; 2015 Jan; 42(1):39-45. PubMed ID: 25393781
[TBL] [Abstract][Full Text] [Related]
25. Serum catalase as marker of graft-vs-host disease in allogeneic bone marrow transplant recipients: pilot study.
Yasmineh WG; Kaur TP; Blazar BR; Theologides A
Clin Chem; 1995 Nov; 41(11):1574-80. PubMed ID: 7586545
[TBL] [Abstract][Full Text] [Related]
26. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease.
Hiejima E; Nakase H; Matsuura M; Honzawa Y; Higuchi H; Saida S; Umeda K; Hiramatsu H; Adachi S; Izawa K; Kawai T; Yasumi T; Nishikomori R; Heike T
Dig Endosc; 2016 Jul; 28(5):548-55. PubMed ID: 26773564
[TBL] [Abstract][Full Text] [Related]
28. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
[TBL] [Abstract][Full Text] [Related]
29. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
[TBL] [Abstract][Full Text] [Related]
30. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
32. [Changes in the skin in transplantation versus host reaction. 2. Our clinical findings from observations using light microscopy and electron microscopy].
Dobrić I; Vujasinović S; Labar B; Bogdanić V; Nemet D; Kastelan A; Baricević B; Vranesić D; Skrinjar L
Lijec Vjesn; 1989 Mar; 111(3):76-80. PubMed ID: 2747408
[TBL] [Abstract][Full Text] [Related]
33. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract][Full Text] [Related]
34. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
35. Changes in protein serum levels during stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; Corrente F; Piccirillo N; Bacigalupo AP; Sica S; Chiusolo P
Eur J Clin Invest; 2017 Oct; 47(10):711-718. PubMed ID: 28796281
[TBL] [Abstract][Full Text] [Related]
36. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
37. [Skin biopsy in diagnosis of chronic graft-versus-host disease in patients after allogeneic haematopoietic stem cell transplantation: pathologist's point of view on quantitative scoring system].
Grzanka D; Styczyński J; Debski R; Krenska A; Pacholska M; Prokurat AI; Wysocki M; Marszałek A
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1105-11. PubMed ID: 19531834
[TBL] [Abstract][Full Text] [Related]
38. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
39. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients.
Militano O; Ozkaynak MF; Mehta B; van deVen C; Hamby C; Cairo MS
Pediatr Blood Cancer; 2018 Aug; 65(8):e27091. PubMed ID: 29667720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
